Pharmacodynamic models can be created for high throughput in vivo screening with hard endpoints across all therapeutic areas.

• Allows efficacy, potency and duration assessment
• Translational to disease model testing, preclinical and clinical development
• We can assess biomarkers in vitro (rodents or clinical samples), in vivo or ex vivo